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Abstract: This case report describes the effect of simultaneous pancreas kidney transplant 
(SPK) on the diabetic retinopathy (DR) of two male type 1 diabetic patients. The literature on 
the effect of SPK on DR is reviewed and the evidence surrounding visual function outcomes 
is discussed.
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Introduction
Pancreas transplants were first used as a treatment for type 1 diabetes in 1966. The initial 
aim of the operation was to improve the quality of life of patients by removing the need 
for repeat blood sugar monitoring and insulin injection. Operative results have been 
successful producing, in those with functioning grafts, not only insulin-independence 
but also euglycemia with normal glycosylated hemoglobin (HbA1C), improvement of 
lipid profiles and normal hypoglycemia responses.1 Besides these primary benefits, 
pancreas transplant has been shown to ameliorate the secondary complications of 
diabetes mellitus including nephropathy, neuropathy, and retinopathy.1 The effect on 
retinopathy, however, is disputed.2 Pancreas transplant alone (PTA), simultaneous 
pancreas kidney transplants (SPK), and pancreas transplant after kidney transplant 
are available options. The dogma is that transplants are beneficial for the treatment of 
retinopathy when carried out early. Two cases illustrating unexpected late recovery of 
visual acuity (VA) after SPK in advanced disease are presented and the literature on 
the effect of transplantation on diabetic retinopathy (DR) is reviewed.
Case reports
A 40-year-old asthmatic man with type 1 diabetes mellitus for fourteen years presented 
with subacute blurred vision of counting fingers (CF) in his right eye and 6/60 in his 
left. He had bilateral vitreous hemorrhages with florid proliferative diabetic retinopathy 
and angle neovascularization. Bilateral cryoretinopexy was followed by bilateral 
vitrectomies and endolaser to try and prevent blindness. Two months after treatment, 
his VA was CF in the right and hand movements (HM) on the left. Over the ensuing 
18 months he required further sequential surgeries including bilateral cataract surgery, 
vitreous washout and supplemental indirect retinal laser, which stabilized the VA to 6/60 
in both eyes (Table 1). Two years later he received a successful SPK. Bilateral Yag laser 
capsulotomies were undertaken three years later. The combination of capsulotomy and Clinical Ophthalmology 2009:3 532
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SPK resulted in stable DR with vision in his right eye recovering 
to 6/12 despite having being registered blind (Figure 1).
The second patient was first seen in 2002, aged 40 years 
with a 20-year history of type 1 diabetes mellitus presenting 
with bilateral proliferative retinopathy and macular edema. 
He had extensive laser treatment to both eyes. His diabetic 
control had always been poor as had his attendance at 
eye appointments. In 2003 a sudden drop in VA from 6/9 
to 6/36 in his left eye prompted re-attendance. Bilateral 
cystoid edema was found and coincided with a diagnosis 
of systemic hypertension (systolic pressures in excess of 
200 mmHg). He received grid and focal laser treatment and 
left intravitreal injection of Kenalog. VA improved to 6/18 in 
his left eye (LE). In 2004 and 2005 he underwent right and 
then left vitrectomy and delamination for severe proliferative 
retinopathy resulting in premacular hemorrhage in his right 
eye (RE) and left disc vessels and macular edema reducing 
vision to HM right and 6/60 left.
By March 2005, VA had improved to 6/9 RE and 6/18 LE. 
Six months later VA dropped to 6/60 LE due to chronic 
cystoid macular edema for which another intravitreal steroid 
injection was given. In March 2006 he underwent left cataract 
surgery with intraocular lens implantation yielding VA 6/9 
RE and 6/24 LE. Hypertension remained a problem causing 
papilledema in December 2006. A SPK was done in January 
2007 and review in February showed markedly improved 
disc appearances. By December 2007, VA was 6/9 RE and 
6/12 LE with stable DR since the transplant with resolution 
of the macular edema. His quality of life was remarkably 
improved.
Both patients, as well as ophthalmology review, had been 
referred to the diabetic service due to poor diabetic control and 
raised HbA1c levels. The diabetes was managed, in both cases, 
with the expected combination of insulin plus best medical 
management with adjuncts such as antihypertensives.
Literature review
The beneficial effect of pancreas transplant on DR is 
debated with an increasing body of evidence supporting its 
efficacy. Improvements seem to be time dependent becoming 
significant after approximately three years.2 In a comparison 
of successful and failed pancreas transplants at two years no 
significant difference was found in degree of retinopathy.3 
However after three years those with functioning grafts had 
no further progression of their retinopathy whilst 70% of 
those with failed transplants had higher grade disease by 
Table 1 Table to show change in visual acuity over time with important clinical events noted
Date  
(month/year)
Visual acuity 
right eye
Visual acuity 
left eye
Events 
11/01 CF 6/60 Diabetic retinopathy with bilateral vitreous 
hemorrhages
01/02 6/60 6/60 Post r vitrectomy and bilateral laser etc
02/02 CF HM Bilateral vitreous hemorrhages
03/02 CF HM Post L vitrectomy
04/02 CF CF Post L phacoemulsification with intra-ocular lens
05/02 CF HM raised intraocular pressure and L vitreous 
hemorrhage
07/02 HM 6/60 raised intraocular pressure and r vitreous 
hemorrhage
11/02 CF 6/60 Post R phacoemulsification with intra-ocular 
lens plus more laser treatment
02/03 6/60 6/60
03/03 6/36 6/36
09/03 6/32 6/36
09/04 6/60 6/60
Simultaneous pancreas kidney transplant performed
08/05 6/18 6/60
08/06 6/12 6/60
07/07 6/12 6/60
04/09 6/12 6/60  Clinical Ophthalmology 2009:3 533
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five years.3 No difference was found in VA. In two other 
studies, stabilization of DR in a 25 SPK patient case series4 
and improvements in the microcirculation of the eye5 in 
SPK versus kidney transplant alone (KTA) occurred by 
three years. This is in comparison to our findings where 
stable improvement in the presented cases occurred after 
only two years and one year, respectively.
A shorter follow-up period does seem to be associated 
with a lack of positive findings in other studies, for example, 
one year after successful SPK versus KTA, despite a signifi-
cant drop in HbA1C with SPK, there was no difference between 
grade of retinopathy in the two groups.6 Immunosuppression 
therapy was the same and blood pressure fell similarly in both 
cases.6 Another study showed no difference at two years in 
the stage of  DR when comparing successful and unsuccessful 
pancreas transplant recipients,7 but less deterioration was 
seen in the successful group after three years.7 No change 
was seen in VA.7 In comparison, one small study showed 
improvement in DR after only one year when comparing 
functioning and nonfunctioning pancreas transplants,8 in 
agreement with the cases presented here but another study of 
SPK failed to show an effect despite long follow-up times.9 
The majority of patients in this latter study had severe prolif-
erative DR pre-transplant, most receiving laser treatment.9 
Despite the lack of improvement, DR grade and VA were 
stabilized by SPK up to the end of the 10 year study.9
The grade of disease pre-pancreas transplant may 
influence the response to transplant. In a comparison of 
diabetics with and without PTA a significant difference 
was found between the number of patients with stabilized 
or improved grade of diabetic retinopathy and macular 
edema except in grade 5 diabetic retinopathy.10 14% of 
those with proliferative retinopathy pre-transplant had 
worsening disease despite successful graft with an average 
30-month follow-up (none less than a year).10 There was 
no significant improvement in VA, intraocular pressures 
or cataract incidence across all grades.10 Another study 
of 30 SPK patients and 12 KTA patients also failed to 
show a difference in VA, and concluded that the disease 
at outset was too advanced to be amenable to benefit.11 
A rodent study, designed to examine the effect of DR 
grade pre-transplant using rats at different stages of DR, 
also supported this theory.12 Sixty rats were split into 
four groups: healthy controls, untreated alloxan-induced 
diabetic, treated with pancreas transplant two weeks 
post-induction of diabetes, and treated with transplant 
12 weeks post-induction. In comparison with diabetic 
controls, within one year early pancreas transplant (two 
weeks versus 12 weeks) significantly reduced cataract 
prevalence whilst later transplant did not. Microscopy 
also showed improved structure of the retina and its blood 
supply in the early transplant group in comparison with 
diabetic controls and late transplant rats. The late transplant 
group showed progression of retinopathy.12 Contrarily, both 
cases presented here had high grade proliferative DR at 
presentation but showed marked improvement.
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The microcirculation of the conjunctiva, when examined 
with intravital microscopy, has been shown to benefit 
from pancreas transplant.13 Significant improvement in 
microangiopathic changes were seen in PTA and SPK when 
compared with type 1 diabetics with and without KTA. 
In fact normalization occurred at 1 year post-SPK but the 
correlation with VA or disease stage was not studied.13 The 
change was attributed to reversal of morphological adaptation 
to glycosylation including arteriole length per area and 
diameter.13 Structural changes were related to improvement 
in function with vascular perfusion increasing in relation to 
length per area. Whether the conjunctival microcirculation can 
be used as a model for the retinal microcirculation is debat-
able. However the significant difference found at 18 months 
post-SPK was seen in none of the controls showing that immu-
nosuppression and normalization of uremia may not factor in 
preventing microangiopathy progression post transplant.13
A study comparing controls, type 1 diabetics, SPK and 
KTA patients measured oxygen pressure, re-oxygenation time 
and velocity of the microcirculation.5 All three parameters 
showed significant improvement after the third year post-
transplant with near normalization of re-oxygenation time. 
This result may indicate that nerve regeneration and repair is 
also occurring allowing improved relaxation of the smooth 
muscle in the vessel walls.5 The study also showed that KTA 
did not influence DR confirming uremia is not of primary 
importance and also that the size of the improvement of the 
microcirculation was proportional to the initial readings, 
ie, that the less diseased the microcirculation was the larger 
the improvement it made after pancreas transplant.5
Many variables change after pancreas transplant including 
euglycemia, physiological levels of insulin, improved lipid pro-
files, blood pressure, and urea levels. No study showed that KTA 
was effective in reducing the grade of DR whereas PTA and 
SPK were both effective, despite a similar fall in blood pressure 
in all transplant patients and normalization of uremia in KTA. 
Therefore, although uremia and hypertension are known to 
exacerbate DR, correcting these factors alone in not enough to 
improve DR. Some evidence that good glucose control is key 
was provided by a large randomized prospective study of 1441 
insulin-dependent diabetics studied over 6.5 years.14 Half the 
patients had mild DR before the study and the other half no DR. 
Patients were randomly assigned to either intensive or normal 
insulin therapy.14 A statistically significant affect on primary 
prevention and progression rate in the secondary prevention 
group was found consistently in all subgroups not affected by 
either sex, blood pressure, age, duration of insulin-dependent 
diabetes mellitus, weight, initial grade of DR, or HbA1C.14 
The group concluded that intensive insulin therapy, whether 
due to euglycemia or euinsulinemia, delays the onset and 
slows the progression of DR after three years and the differ-
ence continues to get more marked with time.14
Visual acuity loss in DR can be caused by a range of 
processes currently recognized including macular ischemia, 
macular edema, epiretinal membrane formation, and vitreous 
hemorrhage. Before any retinopathy is apparent, however, 
using electrophysiological tests, the neuronal network has 
been found to be impaired.15 Therefore the new paradigm 
in the pathophysiology of DR is considering the disease as 
a primary neuronal disease rather than one of the retinal 
microcirculation. It is postulated that the unique physiology 
of the retina makes the neural networks particularly prone to 
oxidative stress such as its high metabolic demands, use of 
glycolysis, sparse vascularity, and low oxygen tension.15
When the VA fails to improve following treatment 
and angiography (indicating a compromised capillary 
circulation), the prognosis for vision is considered poor. 
Perhaps in young patients, like those in the present series, the 
photoreceptor visual potential remains viable and resumes 
its importance when SPK removes the oxidative stress. It is 
proposed that this allows remodeling of the microcirculation, 
once the chronic inflammation resolves, preventing the accu-
mulation of cytokines (resulting in apoptosis and ischemia) 
and promoting the resolution of edema.15 Normal neuronal 
structure and function can then recover.
Despite the lack of evidence of the effect of pancreas trans-
plant on VA and some evidence suggesting that late disease 
is irreversible we have presented two cases of end-stage DR 
demonstrating improvement in VA after SPK. A prospective 
assessment of SPK and visual function in diabetic retinopathy 
would be valuable in providing visual prognosis and potentially 
elucidate the mechanisms of recovery in visual function.
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